Evaluation of the effect of two different antihypertensive treatments on control of glucose in Type II diabetic patients with high blood pressure
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
501
Change from baseline in HbA1c at 5 months
Time frame: 5 months
Blood pressure at 3 and 5 months Body weight at 3 and 5 months Lab levels (glucose, insulin, triglycerides, cholesterol, and albumin:creatinine ratio) at 3 and 5 months.
Time frame: 5 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
GSK Investigational Site
Birmingham, Alabama, United States
GSK Investigational Site
Birmingham, Alabama, United States
GSK Investigational Site
Birmingham, Alabama, United States
GSK Investigational Site
Columbia, Alabama, United States
GSK Investigational Site
Mobile, Alabama, United States
GSK Investigational Site
Derby, Connecticut, United States
GSK Investigational Site
Farmington, Connecticut, United States
GSK Investigational Site
Hartford, Connecticut, United States
GSK Investigational Site
New Britain, Connecticut, United States
GSK Investigational Site
Newark, Delaware, United States
...and 109 more locations